21 CFR 50.20
§ 50.20 General requirements for informed consent.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 50.20, § 50.20 General requirements for informed consent, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/83449
- Permanent ID
ys:prov:83449@1- SHA-256
beb53c99afb81a12770f7a7e54ebf02896685ca3ab44a733b9516612b3ac772e
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
Except as provided in §§ 50.22, 50.23, and 50.24, no investigator may involve a human being as a subject in research covered by these regulations unless the investigator has obtained the legally effective informed consent of the subject or the subject's legally authorized representative. An investigator shall seek such consent only under circumstances that provide the prospective subject or the representative sufficient opportunity to consider whether or not to participate and that minimize the possibility of coercion or undue influence. The information that is given to the subject or the representative shall be in language understandable to the subject or the representative. No informed consent, whether oral or written, may include any exculpatory language through which the subject or the representative is made to waive or appear to waive any of the subject's legal rights, or releases or appears to release the investigator, the sponsor, the institution, or its agents from liability for negligence.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.